Pentwater Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Pentwater Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,190,000	Closed	-$685M	–	134
2025 Q1	$685M	Buy	+5,190,000	New	+$647M	5.75%	4

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Pentwater Capital Management's ITCI Position: Q2 2025 in Review

Pentwater Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 5,190,000 shares — an estimated $685M sold.

Pentwater Capital Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $685M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Pentwater Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Pentwater Capital Management sold 5,190,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $685M.
Pentwater Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Pentwater Capital Management's Intra-Cellular Therapies Inc. position peaked at $685M in Q1 2025.
3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Pentwater Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.